Cynthia Tsai is a seasoned business leader with expertise in finance and entrepreneurship. She is Chairman of the Board of Sethera Therapeutics, a company developing innovative peptide therapies. Tsai's background includes 16 years on Wall Street with Merrill Lynch and General Electric. Previously, she was a General Partner of MassTech Ventures, an MIT-focused fund. Tsai is President of the Board of Montana BioScience Alliance and serves on the Board of Directors of Ethan Allen.

Dr. Eastman received a PhD from the University of Utah under the mentorship of Professor Vahe Bandarian, where they discovered the key processes that enable Sethera Therapeutics’ innovative technology. As a co-founder of Sethera, Dr. Eastman is leading the company’s efforts to commercialize cutting-edge peptide therapeutics, drawing on their experience in enzyme and peptide research, patent development, and engagement with key business mentors.

Professor Vahe Bandarian is a distinguished faculty member and Associate Dean at the University of Utah, recognized for his exceptional contributions to the field of chemistry. He is a Fellow of the American Chemical Society (ACS), the American Association for the Advancement of Science (AAAS), and the American Society for Biochemistry and Molecular Biology (ASBMB). His groundbreaking research has earned him the prestigious Pfizer Award in Enzyme Chemistry from the ACS and the Distinguished Research Award from the University of Utah.

Experienced scientist with a demonstrated expertise in protein engineering and its application in Biotechnology. Strong research professional skilled in computational protein design, experimental protein biochemistry, molecular biology, and bioinformatics. Trained with Nobel Laureate David Baker in protein design and has greater than 10 years of experience working with both large and small companies.

Over a decade of experience in recombinant protein technology with emphasis on synthesis, purification and characterization. Diversified educational background and research in collaborative environment resulted in successful completion of numerous projects. Used computational and data processing skills to develop several high-throughput screening methods for biomolecules. Developed strong leadership and problem-solving skills while mentoring multiple researchers throughout professional career.

Materializing ambitious ideas to answer complex scientific questions and push forward technological innovation. Extensive experience in cutting edge experimental and computational biology, chemistry and physics with an advanced mathematical and theoretical background from a rigorous training in physical chemistry. Currently a molecular biologist focused on cancer profiling and evolution. Parallel ventures in game theory, quantum computing, fluid dynamics and AI.